Guggenheim Capital LLC reduced its holdings in shares of DENTSPLY SIRONA Inc (NASDAQ:XRAY) by 1.3% in the fourth quarter, Holdings Channel reports. The institutional investor owned 715,814 shares of the medical instruments supplier’s stock after selling 9,568 shares during the period. Guggenheim Capital LLC’s holdings in DENTSPLY SIRONA were worth $47,123,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other hedge funds have also made changes to their positions in XRAY. Generation Investment Management LLP increased its holdings in DENTSPLY SIRONA by 115.6% during the fourth quarter. Generation Investment Management LLP now owns 9,011,670 shares of the medical instruments supplier’s stock valued at $593,238,000 after buying an additional 4,831,112 shares during the last quarter. Alyeska Investment Group L.P. boosted its position in shares of DENTSPLY SIRONA by 223.7% in the third quarter. Alyeska Investment Group L.P. now owns 2,271,534 shares of the medical instruments supplier’s stock worth $135,860,000 after purchasing an additional 1,569,746 shares during the period. Frontier Capital Management Co. LLC bought a new position in shares of DENTSPLY SIRONA in the fourth quarter worth approximately $60,449,000. Jackson Square Partners LLC boosted its position in shares of DENTSPLY SIRONA by 15.6% in the third quarter. Jackson Square Partners LLC now owns 6,334,906 shares of the medical instruments supplier’s stock worth $378,890,000 after purchasing an additional 855,199 shares during the period. Finally, Victory Capital Management Inc. boosted its position in shares of DENTSPLY SIRONA by 22,502.5% in the fourth quarter. Victory Capital Management Inc. now owns 855,955 shares of the medical instruments supplier’s stock worth $56,348,000 after purchasing an additional 852,168 shares during the period. 96.80% of the stock is owned by institutional investors and hedge funds.
DENTSPLY SIRONA Inc (NASDAQ XRAY) opened at $56.33 on Friday. The company has a debt-to-equity ratio of 0.24, a quick ratio of 1.46 and a current ratio of 2.12. DENTSPLY SIRONA Inc has a 12-month low of $52.53 and a 12-month high of $68.98. The firm has a market cap of $12,800.00, a price-to-earnings ratio of -8.42, a P/E/G ratio of 2.48 and a beta of 1.20.
DENTSPLY SIRONA (NASDAQ:XRAY) last issued its earnings results on Thursday, March 1st. The medical instruments supplier reported $0.82 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.81 by $0.01. DENTSPLY SIRONA had a negative net margin of 39.39% and a positive return on equity of 8.35%. The firm had revenue of $1.09 billion during the quarter, compared to analyst estimates of $1.06 billion. During the same quarter in the prior year, the business earned $0.67 earnings per share. DENTSPLY SIRONA’s revenue for the quarter was up 9.5% on a year-over-year basis. analysts expect that DENTSPLY SIRONA Inc will post 2.75 EPS for the current year.
The business also recently announced a quarterly dividend, which will be paid on Friday, April 13th. Investors of record on Thursday, March 29th will be given a dividend of $0.0875 per share. The ex-dividend date of this dividend is Wednesday, March 28th. This represents a $0.35 dividend on an annualized basis and a dividend yield of 0.62%. DENTSPLY SIRONA’s dividend payout ratio is -5.23%.
In related news, Director Eric Brandt sold 6,409 shares of the company’s stock in a transaction on Monday, January 8th. The shares were sold at an average price of $68.04, for a total transaction of $436,068.36. Following the completion of the transaction, the director now owns 12,073 shares in the company, valued at $821,446.92. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. 1.99% of the stock is currently owned by corporate insiders.
A number of research firms have weighed in on XRAY. HC Wainwright set a $63.00 price target on shares of DENTSPLY SIRONA and gave the stock a “hold” rating in a research report on Monday, March 5th. Barclays began coverage on shares of DENTSPLY SIRONA in a research report on Thursday, March 8th. They issued an “equal weight” rating and a $62.00 price target for the company. Barrington Research reiterated an “outperform” rating and issued a $70.00 price target (down from $73.00) on shares of DENTSPLY SIRONA in a research report on Monday, March 5th. JPMorgan Chase & Co. dropped their price target on shares of DENTSPLY SIRONA from $75.00 to $70.00 and set an “overweight” rating for the company in a research report on Monday, March 5th. Finally, BidaskClub lowered shares of DENTSPLY SIRONA from a “sell” rating to a “strong sell” rating in a research report on Wednesday, February 28th. Three analysts have rated the stock with a sell rating, four have given a hold rating and nine have assigned a buy rating to the company’s stock. DENTSPLY SIRONA currently has an average rating of “Hold” and a consensus target price of $67.43.
ILLEGAL ACTIVITY WARNING: This piece was first published by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are reading this piece on another domain, it was copied illegally and reposted in violation of United States and international copyright & trademark law. The correct version of this piece can be accessed at https://www.dispatchtribunal.com/2018/03/18/guggenheim-capital-llc-trims-holdings-in-dentsply-sirona-inc-xray.html.
DENTSPLY SIRONA Company Profile
DENTSPLY SIRONA Inc is a manufacturer of professional dental products and technologies. The Company develops, manufactures, and markets solutions offering, including dental and oral health products, as well as other consumable medical devices. It operates through two segments: Dental and Healthcare Consumables, and Technologies.
Want to see what other hedge funds are holding XRAY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DENTSPLY SIRONA Inc (NASDAQ:XRAY).
Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.